Top concern about Ozempic-like drugs has docs worried: ‘All of the benefits are lost’
'...Surveys show that nearly 12% of Americans have turned to Ozempic, Wegovy or similar drugs to lose weight, with prescriptions more than tripling since 2020.
But new research suggests many users are unknowingly sabotaging their progress with one simple mistake. ...scientists in Denmark analyzed data from 77,310 first-time users of semaglutide-based GLP-1s who didn’t have diabetes.'
Reference: nypost.com
Tags:
No comments:
Post a Comment